Technological advancements in fields such as molecular genetics and the human microbiome have resulted in an unprecedented recognition of new bacterial genus/species designations by the International Journal of Systematic and Evolutionary Microbiology. Knowledge of designations involving clinically significant bacterial species would benefit clinical microbiologists in the context of emerging pathogens, performance of accurate organism identification, and antimicrobial susceptibility testing. In anticipation of subsequent taxonomic changes being compiled by the Journal of Clinical Microbiology on a biannual basis, this compendium summarizes novel species and taxonomic revisions specific to bacteria derived from human clinical specimens from the calendar years 2012 through 2015.KEYWORDS anaerobes, bacteria, Gram-negative bacteria, Gram-positive bacteria, taxonomy H uman microbiome studies, particularly those involving genome sequencing, have resulted in a seeming explosion of novel bacterial taxonomy. While many of these organisms appear to play a commensal role in site-specific ecology, some of the organisms may be of clinical significance in various patient populations. Moreover, enhanced studies of known bacterial genomes in a variety of applications, including those of an epidemiologic nature, have given rise to revisions and amendments to accepted bacterial taxonomy. Summaries of microbial taxonomy updates, such as those introduced in this edition of the Journal of Clinical Microbiology, are essential to routine practice in the clinical microbiology laboratory.Since 2014, laboratories subscribing to the College of American Pathologists accreditation program have encountered checklist standard MIC.11375 in the context of biennial inspection exercises. The standard (1) requires laboratories to assimilate "taxonomic changes that potentially affect the choice of appropriate antimicrobials to report and/or the interpretative breakpoints to use." Cited as an example for the context of this standard is the Gram-negative bacillus with the former taxonomic designation Actinobacillus actinomycetemcomitans. The taxonomic revision in 1985 (2) resulting in organism classification within the genus Haemophilus subsequently enabled antimicrobial susceptibility testing of clinically significant isolates using standards outlined in Table 2E of CLSI supplement M100S (example provided in [3]). Haemophilus test medium, with a 16-to 18-hour incubation in 5% CO 2 enrichment, could be utilized for disk diffusion. Haemophilus test medium broth could also be inoculated for broth microdilution testing with 20-to 24-hour incubation in ambient air.Subsequent reclassification of this organism into the genus Aggregatibacter (4) has resulted in the transition of susceptibility testing guidelines to those specific to (former) HACEK group organisms (Aggregatibacter spp., Cardiobacterium spp., Eikenella corrodens, and Kingella spp.) in Table 9 of the CLSI guideline M45 (5).